Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 1,254,436 | 1,191,630 | 1,103,256 | 1,148,560 | 1,018,850 |
| Cost of Goods | 344,000 | 317,000 | 41,000 | 339,410 | 276,180 |
| Gross Profit | 888,000 | 862,000 | 104,000 | 809,160 | 742,670 |
| Operating Expenses | 605,000 | 562,000 | 76,000 | 433,690 | 527,000 |
| Operating Income | 305,436 | 312,630 | 986,256 | 375,870 | 215,850 |
| Interest Expense | 0 | 0 | 0 | 34,590 | 0 |
| Other Income | 1,564 | 2,370 | -951,256 | -12,560 | 44,520 |
| Pre-tax Income | 307,000 | 315,000 | 35,000 | 328,720 | 260,370 |
| Income Tax | 101,000 | 104,000 | 11,000 | 384,810 | N/A |
| Net Income Continuous | 204,672 | 213,345 | 180,432 | 214,740 | 171,760 |
| Net Income | $204,672 | $213,345 | $180,432 | $214,740 | $171,760 |
| EPS Basic Total Ops | 0.03 | 0.03 | 0.03 | N/A | N/A |
| EPS Basic Continuous Ops | 0.03 | 0.03 | 0.03 | N/A | N/A |
| EPS Diluted Total Ops | 0.03 | 0.03 | 0.03 | N/A | N/A |
| EPS Diluted Continuous Ops | 0.03 | 0.03 | 0.03 | N/A | N/A |
| EBITDA(a) | $305,436 | $312,630 | $986,256 | $375,870 | $215,850 |